These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 21568008

  • 1. Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Shanthi M, Sekar U.
    J Assoc Physicians India; 2010 Dec; 58 Suppl():41-4. PubMed ID: 21568008
    [Abstract] [Full Text] [Related]

  • 2. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S, Mallick SK, Bose S.
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO.
    Clin Infect Dis; 2001 Apr 15; 32(8):1162-71. PubMed ID: 11283805
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
    Liao CH, Sheng WH, Wang JT, Sun HY, Wang HK, Hsueh PR, Chen YC, Chang SC.
    J Microbiol Immunol Infect; 2006 Feb 15; 39(1):59-66. PubMed ID: 16440125
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P, Metan G, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2007 Oct 15; 41(4):579-84. PubMed ID: 18173077
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Shakil S, Ali SZ, Akram M, Ali SM, Khan AU.
    J Trop Pediatr; 2010 Apr 15; 56(2):90-6. PubMed ID: 19608665
    [Abstract] [Full Text] [Related]

  • 13. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in spanish hospitals (GEIH-BLEE Project 2002)].
    Hernández JR, Pascual A, Cantón R, Martínez-Martínez L, Grupo de Estudio de Infección Hospitalaria. GEIH.
    Enferm Infecc Microbiol Clin; 2003 Feb 15; 21(2):77-82. PubMed ID: 12586030
    [Abstract] [Full Text] [Related]

  • 14. An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome.
    Nasa P, Juneja D, Singh O, Dang R, Singh A.
    Eur J Intern Med; 2012 Mar 15; 23(2):192-5. PubMed ID: 22284253
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ.
    J Microbiol Immunol Infect; 2011 Oct 15; 44(5):364-8. PubMed ID: 21524974
    [Abstract] [Full Text] [Related]

  • 16. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
    Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, Xie X.
    Intensive Care Med; 2002 Dec 15; 28(12):1718-23. PubMed ID: 12447513
    [Abstract] [Full Text] [Related]

  • 17. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2004 Dec 15; 48(12):4574-81. PubMed ID: 15561828
    [Abstract] [Full Text] [Related]

  • 18. [Nosocomial infection due to ESBL-producing bacteria].
    Yagi T.
    Nihon Rinsho; 2003 Mar 15; 61 Suppl 3():90-4. PubMed ID: 12717952
    [No Abstract] [Full Text] [Related]

  • 19. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F, Ak K, Kucukbasmaci O, Samasti M.
    Chemotherapy; 2009 Mar 15; 55(4):293-7. PubMed ID: 19521075
    [Abstract] [Full Text] [Related]

  • 20. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL, Montaño-Loza A, Rolón AL, Cervantes C, Bobadilla-del-Valle JM, Silva-Sánchez J, Garza-Ramos U, Villasís-Keever A, Galindo-Fraga A, Palacios GM, Ponce-de-León A, Sifuentes-Osornio J.
    Int J Infect Dis; 2008 Nov 15; 12(6):653-9. PubMed ID: 18511321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.